Document:

Exhibit 10.25

 

AMENDMENT

 

TO

 

AGREEMENT DATED MARCH 23, 2004 BY AND BETWEEN

 

LANNETT COMPANY, INC. AND

 

JEROME STEVENS PHARMACEUTICALS, INC.

 

This AMENDMENT to the Supply Agreement (“Amendment”) is entered into as of this 19th day of August, 2013, by and between LANNETT COMPANY, INC., a Delaware corporation with offices located at 13200 Townsend Road, Philadelphia, Pennsylvania 19154 (“LCI”), and JEROME STEVENS PHARMACEUTICALS, INC., a New York corporation with offices located at 60 DaVinci Drive, Bohemia, New York 11716 (“JSP”).

 

BACKGROUND

 

WHEREAS, LCI and JSP entered into a Supply Agreement, dated March 23, 2004 (the “Agreement”), pursuant to which JSP agreed to provide LCI with Butalbital with Aspirin, Caffeine and Codeine Phosphate capsules (“BACC”), Digoxin tablets (“Digoxin”) and Levothyroxine Sodium tablets, as defined in the latest edition of United States Pharmacopeia, sold under the generic name and the brand name “Unithroid” (“Levothyroxine”) (collectively, the “JSP Products”).  (All capitalized terms used and not defined herein will have the meanings given to them in the Agreement.)

 

WHEREAS, the parties now desire to enter into this Amendment to set forth certain changes to and modifications of the terms and conditions contained in the Agreement.

 

NOW, THEREFORE, in consideration of the valuable consideration set forth herein, the sufficiency of which is hereby acknowledged, the parties agree as follows:

 

1.                                      Term.  Paragraph 2 of the Agreement, entitled “Term”, is hereby amended by adding the following at the end thereof:

 

Following the expiration of the initial ten-year term, the term of this Agreement shall be extended for five (5) years, continuing through March 23, 2019 (the “Initial Renewal Term”).  In addition, the parties agree to discuss a mutual extension, to renew this Agreement for an additional five (5) years, continuing through March 23, 2024 (the “Second Renewal Term”). (The Initial Renewal Term and Second Renewal Term, if exercised, will be collectively referred to as the “Renewal Term”).

 

 

2.             Initial Minimum Purchase Order Volumes.  Paragraph 5 of the Agreement, entitled “Initial Minimum Purchase Order Volumes”, shall not apply to the First Renewal Term and, if it takes effect, the Second Renewal Term.  In its place shall be an obligation for LCI to purchase from JSP a minimum of $1.0 Million of BACC capsules, a minimum of $25.0 Million of Levothyroxine Sodium tablets, and a minimum of $ 5.0 Million of Digoxin tablets, in the aggregate, during each year of the First Renewal Term and, if it takes effect, the Second Renewal Term.

 

In the event that such minimum purchase requirements are not met for any one or more JSP Product in any given year, JSP reserves the right to reclaim the product marketing and distribution rights for such JSP Product and LCI agrees to transition such business to JSP.  For clarity, the parties agree that JSP will not have the right or ability to reclaim any JSP Product for which LCI meets the above minimum purchase requirements.

 

3.             Joint Sales Meetings.  Every three (3) months (quarterly) during the First Renewal Term and, if it takes effect, the Second Renewal Term, the relevant JSP and LCI staff will conduct a joint evaluation of sales during the prior quarter, with the intention of renewing or evaluating the level of purchasing currently in place for the trailing twelve months. Should the need arise, this meeting shall also be used to arrange to transition the JSP products back to JSP.  Such transition shall include LCI using its best efforts to obtain written consent of customers to transfer to JSP any agreements and any of LCI’s rights or obligations under such agreements should Lannett decided not to renew or if JSP and LCI are unable to agree on terms for the Second Renewal Term.

 

4.             Consideration.  Paragraph 11 of the Agreement, entitled “Consideration”, shall not apply to the First Renewal Term and, if it takes effect, the Second Renewal Term.  In lieu thereof, the parties agree, that:  (a)  LCI shall issue to JSP (or its nominee(s)) one million five hundred thousand (1,500,000) shares of restricted common stock of LCI (“LCI Shares”) effective as of the date of this Amendment; and (b)  if the Second Renewal Term should take effect, LCI shall issue to JSP (or its nominee(s)) one million five hundred thousand (1,500,000) shares of restricted common stock of LCI as of the effective date of the Second Renewal Term (i.e., March 24, 2019). Such shares of common stock shall be delivered free and clear of all lien and/or encumbrances, with all required transfer taxes, if any, paid or provided for.

 

5.             Restrictions on Transfer of Shares.  JSP agrees, on behalf of itself and all nominee(s) who receive any LCI Shares (collectively, the “Nominees”), that, until after March 24, 2014, neither it nor they shall, directly or indirectly, without the prior written approval of LCI:  (a) offer, sell, assign, transfer, pledge, contract to sell, or otherwise dispose of any of the LCI Shares issued under Section 4(a) above (the “First Renewal

 

2

 

Shares”); (b) enter into any swap, hedge or other agreement or arrangement that transfers in whole or in part, the economic risk of ownership of any of the First Renewal Shares; or (c) engage in any short selling of any of the First Renewal Shares. Each Certificate issued with respect to the LCI Shares shall include an appropriate legend with regard to the restrictions set forth in this Section.  Such Certificates may be re-issued after March 24, 2014 without such legend.

 

6.             Proxy.  JSP, on behalf of itself and all Nominees, hereby irrevocably grants to Arthur Bedrosian, as the President and Chief Executive Officer of LCI (“Bedrosian”), and appoints Bedrosian (with full power of substitution) as its and their irrevocable proxy to vote, abstain from voting, execute and deliver written consents, and/or take any other action whatsoever in respect of the LCI Shares during the period of time between the date of this Amendment and March 24, 2014, as fully, to the same extent and with the same effect as JSP and the Nominees might or could do under applicable law.  This proxy may be exercised by Bedrosian on any one or more occasions.  JSP, on behalf of itself and all Nominees, hereby further affirms that this irrevocable proxy is coupled with an interest and may under no circumstances be revoked. JSP, on behalf of itself and all Nominees, ratifies and confirms all that Bedrosian may lawfully do or cause to be done by virtue hereof.  This proxy shall expire on March 25, 2014.

 

7.             Separate Documents for Nominees.  If requested by LCI, each of the Nominees shall be required to sign and deliver to LCI, as a condition precedent to their receipt of Certificates evidencing their portion of the LCI Shares, a document affirming their agreement to be bound by Sections 5 and 6 above, including, but not limited to, an irrevocable proxy in a form acceptable to LCI.

 

8.             Return of Unithroid.  The parties will continue to negotiate the nature, form and process for the return of the Unithroid brand name for further sales by JSP at brand prices.  It is understood that the price differences between the resale of JSP manufactured Levothyroxine Sodium sold under LCI’s label will not be in conflict with the selling price of Unithroid sold at brand prices by JSP or others.  All branding opportunities developed by LCI for the Unithroid brand will be transferred to JSP.  The parties agree to use their best efforts to finalize such negotiations by no later than December 31, 2013.

 

9.             Non-Compete Covenant.  For the duration of the First Renewal Term and, if it takes effect, the Second Renewal Term, LCI agrees not to submit any applications to the U.S. Food and Drug Administration for any of the JSP Products or to distribute to its customers any products that compete with any of the JSP Products, nor to enter into any agreement with a third party to distribute the JSP Products from a competing source.

 

3

 

10.          Sale of Business.  If, during the First Renewal Term and, if it takes effect, the Second Renewal Term, LCI enters into any negotiations for the sale of LCI, LCI will notify JSP so that preparations can be taken and options can be considered.

 

11.          Repackaging.  LCI agrees to use commercially reasonable efforts to identify and qualify any of its customers that indicate to LCI that they intend to repack or repackage any of the JSP Products.

 

12.          Notices.  The last sentence of Paragraph 11 of the Agreement is hereby deleted and replaced with the following:

 

A copy of any notice sent to LCI shall also be sent to:

 

Samuel H. Israel, Esquire

Fox Rothschild LLP

2000 Market Street

20th Floor

Philadelphia, PA 19103

 

13.          Agreement.  Unless the context clearly indicates otherwise, all references to the term “Agreement” contained in the Agreement and/or this Amendment will mean the Agreement as amended hereby.

 

14.          Counterparts.  This Amendment may be executed in counterparts, each of which will be deemed an original, but all of which together will constitute one and the same instrument.

 

15.          Miscellaneous.  All terms and provisions of the Agreement that are not expressly amended or modified by this Amendment will remain in full force and effect. In the event of any conflict between any of the terms of the Agreement and the terms of this Amendment, the terms of this Amendment will control.

 

4

 

IN WITNESS WHEREOF, the parties hereto have caused this Amendment to be executed effective as of the date first indicated above.

 

	
LANNETT   COMPANY, INC.
    	
 
    
	
 
    	
 
    
	
 
    	
 
    	
 
    
	
By:
    	
/s/   Arthur Bedrosian
    	
 
    
	
 
    	
Arthur   Bedrosian, President & CEO
    	
 
    
	
 
    	
 
    
	
 
    	
 
    
	
JEROME   STEVENS PHARMACEUTICALS, INC.
    	
 
    
	
 
    	
 
    
	
By:
    	
/s/   Jerome Steinlauf
    	
 
    
	
 
    	
Jerome   Steinlauf, President
    	
 
    

 

5Exhibit 10.1

 

EXECUTION COPY

 

EMPLOYMENT AGREEMENT

 

THIS EMPLOYMENT AGREEMENT (this “Agreement”) is executed on August 19, 2013 (the “Effective Date”) by and between Tuesday Morning Corporation, a Delaware corporation (the “Company”), and R. Michael Rouleau (the “Executive”).  The Company and the Executive shall be referred to herein as the “Parties.”

 

RECITALS

 

WHEREAS, the Company and the Executive desire to set forth in writing the terms and conditions of their agreement and understandings with respect to the employment of the Executive; and

 

WHEREAS, the Company hereby agrees to employ the Executive, and the Executive hereby accepts employment with the Company for the period and upon the terms and conditions contained in this Agreement.

 

NOW, THEREFORE, in consideration of the mutual promises and agreements contained herein, and other good and valuable consideration, the receipt and sufficiency of which are hereby acknowledged, and intending to be legally bound, the Parties hereby agree as follows:

 

ARTICLE I.

SERVICES TO BE PROVIDED BY THE EXECUTIVE

 

A.                                    Position and Responsibilities.  The Executive shall serve in the position of Chief Executive Officer (“CEO”) of the Company or such other position in the future to which the Company’s board of directors (the “Board”) may appoint Executive from time to time, and shall perform services for the Company as requested or as needed to perform the Executive’s job.  The duties of the Executive shall be those duties which can reasonably be expected to be performed by a person in such position, and while serving as CEO, the Executive shall have the authority commensurate with the position of chief executive officer of a publicly held company in the United States.  The Executive shall report directly to the Board.

 

B.                                    Performance.  During the Executive’s employment with the Company, the Executive shall devote a substantial portion of the Executive’s time, energy, skill and best efforts to the performance of the Executive’s duties hereunder in a manner that will faithfully and diligently further the business and interests of the Company, and shall exercise reasonable best efforts to perform the Executive’s duties in a diligent, trustworthy, good faith and business-like manner, all for the purpose of advancing the business of the Company.  The Executive shall at all times act in a manner consistent with the Executive’s position.  The Company and the Executive acknowledge and agree that performance of the Executive’s duties hereunder shall not require the Executive to be at Company’s headquarters during all business hours.

 

C.                                    Compliance.  The Executive agrees to act in accordance with high business and ethical standards at all times.  The Executive shall comply with the policies, codes of conduct, codes of ethics, written manuals and lawful directives of the Company.  The Executive shall use his best judgment in complying with all applicable laws, and shall have access to Company counsel for advice and counsel accordingly.  The Company shall not loan or advance the Executive any money.  The Executive shall

 

1

 

keep the Board through its Chairman promptly and fully informed of the Executive’s conduct in connection with the business affairs of the Company.

 

D.                                    Representations.  The Executive may manage the Executive’s own passive investments, participate in civic, religious, educational or professional organizations, and after the first anniversary of the Effective Date, may serve, with the consent of the Board, on the board of directors (and any board committees) of not more than one for-profit company that does not compete with the Company; provided that such activities do not, individually or in the aggregate, materially interfere with the Executive’s obligations to the Company.  The Executive represents to the Company that Executive (i) is not violating and will not violate any contractual, legal, or fiduciary obligations or burdens to which the Executive is subject by entering into this Agreement or providing services under the Agreement’s terms; (ii) is under no contractual, legal, or fiduciary obligation or burden that will interfere with the Executive’s ability to perform services under the Agreement’s terms; (iii) is not bound by the terms of any agreement with any previous employer or other party to refrain from using or disclosing any trade secret or confidential or proprietary information in the course of the Executive’s employment with the Company or to refrain from competing, directly or indirectly, with the business of such previous employer or any other party, that has not been disclosed in writing to the Board; and (iv) has no personal bankruptcies, convictions, disputes with regulatory agencies, or other discloseable or disqualifying events that would have any material impact on the Company or its ability to conduct securities offerings that have not been disclosed in writing to the Board.  The Executive further represents that the Executive’s performance of all the terms of this Agreement and the Executive’s work duties for the Company do not and will not breach any agreement to keep in confidence proprietary information, knowledge or data acquired by the Executive in confidence or in trust prior to the Executive’s employment with the Company.  The Executive shall not disclose to the Company or induce the Company to use any confidential or proprietary information or material belonging of any previous employer or others.

 

ARTICLE II.

COMPENSATION FOR SERVICES

 

As compensation for all services the Executive will perform under this Agreement, the Company will pay the Executive, and the Executive shall accept as full compensation, the following:

 

A.                                    Signing Bonus.  Within thirty (30) days of the Effective Date, the Company will pay the Executive in a lump sum the amount of five hundred seventy-five thousand dollars ($575,000.00).

 

B.                                    Base Compensation.  During the Employment Term, the Company shall pay the Executive an aggregate base salary in the initial amount of forty-six thousand six hundred and sixty-six dollars and sixty-six cents ($46,666.66) per month (five hundred sixty thousand dollars ($560,000.00) annually) (the “Base Salary”).  The Base Salary may be reviewed annually by the Board and may be increased from time to time during the tenure of the Executive as CEO; provided, however, if the Executive remains employed by the Company but is no longer CEO, the Base Salary may be increased or decreased, but in no case shall the Base Salary be less than sixteen thousand six hundred and sixty-six dollars and sixty-six cents ($16,666.66) per month (two hundred thousand dollars ($200,000.00) annually).  The Base Compensation shall be payable in accordance with the Company’s current payroll process and modified to be consistent with any change in the Company’s policy.

 

C.                                    Annual Bonus.  For each fiscal year of the Company during the Employment Term (as hereinafter defined), and except as otherwise provided herein, the Executive will be eligible to earn a bonus under the Tuesday Morning Corporation Corporate Executive Annual Incentive Plan (or any successor plan thereto) (the “Annual Bonus”).

 

2

 

D.                                    Equity Grant.

 

(i)                                     Initial Grant. No sooner than three (3) and no later than ten (10) days following the Effective Date, the Company, subject to approval of the Board or the Compensation Committee of the Board, shall grant the Executive a one-time grant under the Tuesday Morning Corporation 2008 Long-Term Equity Incentive Plan (the “Plan”) options to purchase three hundred fifty thousand (350,000) shares of the Company’s common stock (the “Shares”) and thirty thousand (30,000) shares of Restricted Stock (as defined in the Plan) (the “Restricted Stock”) (collectively, the “Initial Grant”).  The Initial Grant shall be subject to the terms and conditions of the Plan and the Company’s standard forms of Restricted Stock agreement and option agreement, which option agreement terms shall include an exercise price equal to the fair market value of the Company’s common stock on the date of grant.

 

(ii)                                  Vesting.  Except as otherwise provided in this Agreement,

 

(a)                                 the Initial Grant shall vest as follows:

 

(1)  Options to purchase seventy-five thousand (75,000) Shares shall vest six (6) weeks after the Effective Date.

 

(2)  Options to purchase seventy-five thousand (75,000) Shares shall vest six (6) months after the Effective Date.

 

(3)  Fifteen thousand (15,000) shares of Restricted Stock shall vest six (6) months after the Effective Date.

 

(4)  Options to purchase seventy-five thousand (75,000) Shares shall vest twelve (12) months after the Effective Date.

 

(5)               Fifteen thousand (15,000) shares of Restricted Stock shall vest twelve (12) months after the Effective Date.

 

(6)  Options to purchase seventy-five thousand (75,000) Shares shall vest eighteen (18) months after the Effective Date.

 

(7)  Options to purchase fifty thousand (50,000) Shares shall vest twenty-four (24) months after the Effective Date.

 

b)                                     In the event, at any annual election of directors, the Board fails to nominate Executive for reelection to the Board, or if following nomination, the shareholders fail to reelect Executive, all unvested options and all unvested shares of Restricted Stock shall vest on the day following such failure to nominate or reelect, as applicable.

 

E.                                     Expenses.  The Company agrees that, during the Employment Term, it will reimburse the Executive for out-of-pocket expenses reasonably incurred in connection with the Executive’s performance of the Executive’s services hereunder, including without limitation, commuting expenses for the Executive and, from time to time, his spouse (including air travel, hotel, and similar expenses related to commuting from his primary residence), travel and entertainment expenses incurred by the Executive in connection with the business of the Company.  All such reimbursements shall be paid upon the presentation by the Executive of an itemized accounting of such expenditures, with supporting receipts.

 

3

 

Reimbursement shall be in compliance with the Company’s expense reimbursement policies.  Any reimbursement of expenses made under this Article II.E. shall only be made for eligible expenses incurred during the Employment Term, and no reimbursement of any expense shall be made by the Company after December 31st of the year following the calendar year in which the expense was incurred.  The amount eligible for reimbursement under this Article II.E. during a taxable year may not affect expenses eligible for reimbursement in any other taxable year, and the right to reimbursement under this Article II.E. is not subject to liquidation or exchange for another benefit.

 

F.                                      Other Benefits. During the Employment Term and subject to any contribution therefor generally required of executives of the Company, the Executive shall be entitled to participate in all employee benefit plans, including without limitation the Company’s retirement 401(k) plan, health and dental plan, life insurance and disability plans as from time to time adopted by the Board and in effect for executives of the Company generally.  Such participation shall be subject to (i) the terms of the applicable plan documents, and (ii) generally applicable policies of the Company.  The Company may alter, modify, add to or delete the employee benefit plans at any time as the Board, in its sole judgment, determines to be appropriate, so long as the Executive is treated in the same manner as other similarly-situated executives.

 

G.                                    Attorney’s Fees.  The Company agrees to pay or reimburse Executive for the reasonable attorney fees incurred by Executive in connection with the review of this Agreement and any related documents, up to a maximum of seven thousand five hundred dollars ($7,500.00).  Such payment will be made promptly following the date Executive commences employment with the Company, upon receipt by the Company of an appropriate invoice from the attorney for the fees with respect to such review.

 

ARTICLE III.
  TERM; TERMINATION

 

A.                                    Term of Employment.  Subject to earlier termination as herein provided, the Executive’s employment under this Agreement shall begin on the Effective Date and shall continue in effect until the second anniversary of the Effective Date (the “Initial Term”).  The Agreement will automatically renew, subject to earlier termination as herein provided, for successive one (1) year periods (the “Additional Terms”), unless either the Executive or the Company provide notice of non-renewal at least ninety (90) days prior to the expiration of the Initial Term or the then Additional Term, whichever is applicable.  The Initial Term and any Additional Term(s) shall be referred to collectively as the “Employment Term.”

 

B.                                    Termination.  Notwithstanding the provisions of Article III.A. hereof and subject to Article III.C. hereof, the Executive’s employment with the Company shall terminate prior to or upon the expiration of the Initial Term or then Additional Term under the circumstances set forth below.  Unless otherwise agreed to by the Board, the Executive’s termination under this Agreement for any reason shall also constitute the Executive’s resignation as an officer and director of the Company and any affiliate or subsidiary of the Company, as applicable.  The Company and the Executive shall take all steps necessary (including with regard to any post-termination services by the Executive) to ensure that any termination described in this Article III.B. constitutes a “separation from service” within the meaning of Section 409A of the Internal Revenue Code of 1986, as amended (the “Code”); provided that if a termination described in this Article III.B. does not constitute a separation from service, the Executive’s right to any payments described in this Article III.B. which are being paid with respect to such separation from service shall vest on the date of termination, but payment of any amounts subject to Code Section 409A shall be deferred until the Executive incurs a separation from service (or six months thereafter if Article III.C. applies), or the Executive’s death.  Any such payment made in accordance with this Article III.B. shall be treated as a separate payment for purposes of Code Section 409A to the extent Code Section 409A applies to such payments.

 

4

 

(i)                                     Death or Disability.  In the event of the Executive’s death or Disability, the Executive’s employment shall immediately terminate.  The Company shall have no further liability or obligation to the Executive under this Agreement or in connection with the Executive’s employment hereunder, except for (i) any accrued, unpaid Base Salary through the date of termination; (ii) any payments or benefits provided under the terms and conditions of the employee benefit plans of the Company in which the Executive is a participant on the date of termination; (iii) any unreimbursed expenses properly incurred prior to the date of termination; and (iv) except in the case of a termination by the Company for Cause (as hereinafter defined) or resignation by the Executive without Good Reason (as hereinafter defined), any Annual Bonus earned for the fiscal year prior to the year of termination but not yet paid as of the date of termination (collectively, the “Accrued Obligations”).  The Accrued Obligations shall be payable in a lump sum within the time period required by applicable law, and in no event later than thirty (30) days following termination of employment.  The Company will also pay a prorated bonus for the fiscal year of termination payable at the same time as bonuses would otherwise be payable under the Company’s bonus plan, as then in effect, subject to the achievement of applicable performance goals for the performance period.  In addition, the portion of the Initial Grant described in Article II.D.(ii)(a)(1), (2) and (3), to the extent unvested, shall become 100% vested as of the date of such death or Disability, and the vested portion of all of the options shall remain exercisable until the earlier of (1) the date that is two years following the Executive’s death or Disability or (2) the last day of the original term of the Initial Grant.  For purposes of this Agreement, “Disability” means the Executive’s disability for purposes of entitlement to disability benefits under the Company’s Long-Term Disability Plan.

 

(ii)                                  Termination for Cause or Voluntary Termination without Good Reason.  In the event the Company terminates the Executive’s employment for Cause (as hereinafter defined) or the Executive voluntarily terminates the Executive’s employment without Good Reason (as hereinafter defined), the Company shall have no further liability or obligation to the Executive under this Agreement or in connection with Executive’s employment hereunder, except for the applicable Accrued Obligations.  The Accrued Obligations shall be payable in a lump sum within the time period required by applicable law, and in no event later than thirty (30) days following termination of employment.  For purposes of this Agreement, “Cause” means termination because of: (i) an act or acts of theft, embezzlement, fraud, or dishonesty; (ii) any willful misconduct or gross negligence by the Executive with regard to the Company; (iii) any violation by the Executive of any fiduciary duties owed by him to the Company; (iv) the Executive’s conviction of, or pleading nolo contendere or guilty to, a felony (other than a traffic infraction) or misdemeanor that may cause damage to the Company or the Company’s reputation; (v) a material violation of the Company’s written policies, standards or guidelines, which the Executive failed to cure within thirty (30) days after receiving written notice from the Board specifying the alleged violation; (vi) the Executive’s willful failure or refusal to satisfactorily perform the duties and responsibilities required to be performed by the Executive under the terms of this Agreement or necessary to carry out the Executive’s job duties, which the Executive failed to cure within thirty (30) days after receiving written notice from the Board specifying the alleged willful failure or refusal; and (vii) a material breach by the Executive of this Agreement or any other agreement to which the Executive and the Company are Parties that is not cured by the Executive within twenty (20) days after receipt by the Executive of a written notice from the Company of such breach specifying the details thereof.  For purposes of this Agreement, “Good Reason” means a material breach by the Company of this Agreement, or any other agreement related to Executive’s services to the Company to which the Executive and the Company are parties.  The foregoing event shall not constitute Good Reason unless the Executive delivers to the Company a written notice of termination for Good Reason specifying the alleged Good Reason within ninety (90)

 

5

 

days after the Executive first learns of the existence of the circumstances giving rise to Good Reason, within thirty (30) days following delivery of such notice, the Company has failed to cure the circumstances giving rise to Good Reason, and the Executive resigns within sixty (60) days after the end of the cure period.

 

(iii)                               Termination without Cause or Termination by the Executive with Good Reason Prior to a Change in Control.  In the event the Company terminates the Executive’s employment without Cause or the Executive terminates the Executive’s employment with Good Reason prior to a Change in Control (as hereinafter defined), the Company shall pay the following amounts to the Executive:

 

(a)                                 the Accrued Obligations, payable in a lump sum within the time period required by applicable law, and in no event later than thirty (30) days following termination of employment;

 

(b)                                 subject to compliance with the restrictive covenants in Article IV and the execution and timely return by the Executive of the Release (as defined in Article III.B.(vi)), and subject to the provisions of Article III.C. below:

 

1.                                      Continuation of the payment of his Base Salary owing for the remainder of the Initial Term, if any, payable monthly as provided for in Article II.B.

 

2.                                      In addition, the Company shall pay the Executive a prorated bonus for the fiscal year of termination payable at the same time as bonuses would otherwise be payable under the Company’s bonus plan (as then in effect), subject to the achievement of applicable performance goals for the performance period.

 

3.                                      the Initial Grant, to the extent unvested, shall become 100% vested as of the date of such termination, and the vested portion of all of the options shall remain exercisable until the earlier of (1) the date that is two years following the Executive’s termination of employment or (2) the last day of the original term of the Initial Grant.

 

4.                                      In the event the Executive fails to comply with the restrictive covenants in Article IV or does not timely execute and return (or otherwise revokes) the Release, no amount shall be payable to the Executive and no additional vesting of the Initial Grant shall occur pursuant to this Article III.B.(iii)(b).

 

(iv)                              Termination without Cause or Termination by the Executive with Good Reason On or After a Change in Control.     In the event that on or after a Change in Control the Company terminates the Executive’s employment without Cause or the Executive terminates his employment with Good Reason, the Executive shall be entitled to the benefits provided for in Article III.B.(iii). above, subject to any terms set forth therein.  For purposes of Article III.B.(iii) and this Article III.B.(iv), “Change in Control” shall have the same meaning as the term “Change in Control” in the Plan.

 

(v)                                 Non-Renewal.  The Executive’s employment shall terminate for non-renewal at the end of the Initial Term or the then Additional Term if at least ninety (90) days prior to the end

 

6

 

of the Initial Term or the then Additional Term, the Company or the Executive has notified the other in writing that the Employment Term shall terminate at the end of the then current term.  Upon a nonrenewal of this Agreement, the Executive shall be entitled to (A) the Accrued Obligations, payable in a lump sum within the time period required by applicable law, and in no event later than thirty (30) days following termination of employment and (B) any options granted in the Initial Grant that are vested as of the end of the Initial Term or the then Additional Term, as applicable.

 

(vi)                              Release.  For purposes of this Agreement, the “Release” shall mean a release of, and covenant not to sue with respect to, any claims that the Executive may have against the Company, or its directors, officers, employees and affiliates, arising out of or related to the Executive’s employment by the Company or the termination of such employment, except for the Executive’s right to payments pursuant to this Article III and amounts payable after termination of employment under any equity grants, and claims that cannot by law be released.  The Release shall be in a form and substance reasonably requested by the Company.  The Release shall also provide for all released parties to release any claims against the Executive not involving fraud, breach of fiduciary duty or illegal conduct.  The Release shall be furnished to the Executive not later than five (5) days after his termination, and must be executed and returned to the Company, and any revocation period provided in the Release must have expired, not later than sixty (60) days after the date of termination, in order for the Executive to be eligible to receive the benefits described in Article III.B.(iii)(b) or such benefits described in Article III.B.(iv).  No amount described in Article III.B.(iii)(b) or similar amount described in Article III.B.(iv) shall be paid to the Executive until the date on which the revocation period expires, and all amounts that would otherwise have been paid prior to such date shall be paid as soon as practical after such date; provided, however, that if the sixtieth day after the date of termination falls in the calendar year after the year that includes the date of termination, no amount described in Article III.B.(iii) or Article III.B.(iv) that is subject to Code Section 409A shall be paid before the first day of such following calendar year.

 

C.                                    Six-Month Delay of Payments.  To the extent that (i) any payments to which the Executive becomes entitled under this Agreement, or any agreement or plan referenced herein, in connection with the Executive’s termination of employment with the Company constitute “deferred compensation” subject to Code Section 409A and (ii) the Executive is deemed at the time of such termination of employment to be a “specified employee” under Code Section 409A, then such payment or payments shall not be made or commence until the earliest of (A) the expiration of the six (6) month period measured from the date of the Executive’s “separation from service” (as such term is defined in the final regulations issued under Code Section 409A) with the Company; or (B) the date of the Executive’s death following such separation from service. Upon expiration of the applicable deferral period, any payments which would have otherwise been made during that period (whether in a single sum or in installments) in the absence of this Article III.C. shall be paid to the Executive (or, in the case of the Executive’s death, his estate) in one lump sum.

 

D.                                    Survival.  The provisions of this Agreement, including, without limitation, the Executive’s post-termination obligations in Article IV., shall survive the termination of this Agreement, and of the Employment Term, for any reason, to the extent necessary to enable the Parties to enforce their respective rights hereunder.

 

7

 

ARTICLE IV.
  RESTRICTIVE COVENANTS

 

A.                                    Confidentiality.

 

(i)                                     Confidential Information. During the Executive’s employment with the Company, the Company shall grant the Executive otherwise prohibited access to its trade secrets and confidential information which is not known to the Company’s competitors or within the Company’s industry generally, which was developed by the Company over a long period of time and/or at its substantial expense, and which is of great competitive value to the Company, and access to the Company’s customers and clients.  For purposes of this Agreement, “Confidential Information” includes any trade secrets or confidential or proprietary information of the Company, including, but not limited to, the following:  products, services, processes, equipment, know-how, technical data, policies, strategies, designs, formulas, developmental or experimental work, improvements, discoveries, research, plans for research or future products and services, database schemas or tables, development tools or techniques, training procedures, training techniques, training manuals, business information, marketing and sales plans and strategies, business plans, budgets, financial data and information, customer and client information, prices and costs, customer and client lists and profiles, employee, customer and client nonpublic personal information, supplier lists, business records, product construction, product specifications, audit processes, pricing strategies, business strategies, marketing and promotional practices, management methods and information, plans, reports, recommendations and conclusions, information regarding the skills and compensation of employees and contractors of the Company, and other business information disclosed to the Executive by the Company, either directly or indirectly, in writing, orally, electronically, or by drawings or observation; provided however, Confidential Information does not include information that becomes generally available to the public other than as a result of a disclosure by the Executive (unless such disclosure was made in the course of the Executive’s duties) or becomes available to the Executive on a non-confidential basis from a source other than the Company or any subsidiaries thereof or any of their employees, so long as that source is not prohibited from disclosing such information or data without restriction on disclosure or use.

 

(ii)                                  No Unauthorized Use or Disclosure.  The Executive acknowledges and agrees that Confidential Information is proprietary to and a trade secret of the Company and, as such, is a special and unique asset of the Company, and that any disclosure or unauthorized use of any Confidential Information by the Executive may cause irreparable harm and loss to the Company.  The Executive understands and acknowledges that each and every component of the Confidential Information (i) has been developed by the Company at significant effort and expense and is sufficiently secret to derive economic value from not being generally known to other Parties, and (ii) constitutes a protectable business interest of the Company.  The Executive agrees not to dispute, contest, or deny any such ownership rights either during or after the Executive’s employment with the Company.  The Executive agrees to preserve and protect the confidentiality of all Confidential Information.  The Executive agrees that the Executive shall not at any time (whether during or after the Executive’s employment), directly or indirectly, disclose to any unauthorized person or use for the Executive’s own account any Confidential Information without the Company’s consent.  Throughout the Executive’s employment and at all times thereafter: (i) the Executive shall hold all Confidential Information in the strictest confidence, take all reasonable precautions to prevent its inadvertent disclosure to any unauthorized person, and follow all policies of the Company protecting the Confidential Information; and (ii) the Executive shall not, directly or indirectly, utilize, disclose or make available to any other person or entity, any of the Confidential Information, other than in the proper performance of the Executive’s

 

8

 

duties.  Further, the Executive shall not, directly or indirectly, use the Company’s Confidential Information to: (1) call upon, solicit business from, attempt to conduct business with, conduct business with, interfere with or divert business away from any customer, client, vendor or supplier of the Company with whom or which the Company conducted business; and/or (2) recruit, solicit, hire or attempt to recruit, solicit, or hire, directly or by assisting others, any persons employed by the Company.  If the Executive learns that any person or entity is taking or threatening to take any actions which would compromise any Confidential Information, the Executive shall promptly advise the Company of all facts concerning such action or threatened action.  The Executive shall use all reasonable efforts to obligate all persons to whom any Confidential Information shall be disclosed by the Executive hereunder to preserve and protect the confidentiality of such Confidential Information.

 

(iii)                               Return of Property and Information.  Upon the termination of the Executive’s employment for any reason, the Executive shall immediately return and deliver to the Company any and all Confidential Information, software, devices, cell phones, personal data assistants, credit cards, data, reports, proposals, lists, correspondence, materials, equipment, computers, hard drives, papers, books, records, documents, memoranda, manuals, e-mail, electronic or magnetic recordings or data, including all copies thereof, which belong to the Company or relate to the Company’s business and which are in the Executive’s possession, custody or control, whether prepared by the Executive or others.  If at any time after termination of the Executive’s employment the Executive determines that the Executive has any Confidential Information in the Executive’s possession or control, the Executive shall immediately return to the Company all such Confidential Information in the Executive’s possession or control, including all copies and portions thereof.

 

B.                                    Restrictive Covenants.  In consideration for (i) the Company’s promise to provide Confidential Information to the Executive, (ii) the substantial economic investment made by the Company in the Confidential Information and goodwill of the Company, and/or the business opportunities disclosed or entrusted to the Executive, (iii) access to the Company’s customers and clients, and (iv) the Company’s employment of the Executive pursuant to this Agreement and the compensation and other benefits provided by the Company to the Executive, to protect the Company’s Confidential Information and business goodwill of the Company, the Executive agrees to the following restrictive covenants.

 

(i)                                     Non-Competition.  The Executive agrees that during the Restricted Period (as hereinafter defined), other than in connection with the Executive’s duties under this Agreement, the Executive shall not, and shall not use any Confidential Information to, without the prior written consent of the Company, directly or indirectly, either individually or as a principal, partner, stockholder, manager, agent, consultant, contractor, distributor, employee, lender, investor, or as a director or officer of any corporation or association, or in any other manner or capacity whatsoever, become employed by, control, manage, carry on, join, lend money for, operate, engage in, establish, perform services for, invest in, solicit investors for, consult for, do business with or otherwise engage in any Competing Business (as hereinafter defined) within the Restricted Area (as hereinafter defined).  Notwithstanding the restrictions contained in this Article IV.B.(i), the Executive may own an aggregate of not more than 2% of the outstanding stock of any class of any corporation engaged in a Competing Business, if such stock is listed on a national securities exchange in the United States (or a comparable exchange in a foreign jurisdiction) or regularly traded in the over-the-counter market by a member of a national securities exchange in the United States, without violating the provisions of this Article IV.B.(i); provided, however, that the Executive does not have the power, directly or indirectly, to control or direct the management or affairs of any such corporation and is not involved in the management of such corporation.

 

9

 

For purposes of this Agreement:

 

(a)                                 “Restricted Period” means during the Executive’s employment with the Company and for a period of one (1) year immediately following the date of the Executive’s termination from employment for any reason.

 

(b)                                 As Chief Executive Officer of the Company, the Executive has responsibility for the Company’s operations throughout the United States of America and access to the highest levels of the Company’s Confidential Information and business goodwill.  Therefore, the “Restricted Area” includes the United States.

 

(c)                                  “Competing Business” means any business, individual, partnership, firm, corporation or other entity that is competing or that is preparing to compete with any aspect of the Company’s business, which includes, but is not limited to, any retailer of general merchandise, department store and any other business specializing in high-quality home furnishings, housewares or gift related items in the United States; and any other business the Company conducted, prepared to conduct or materially contemplated conducting during the Executive’s employment with the Company.  Competing Business shall include business of the type of, but not be limited to, the following entities: Nordstrom, Inc., the TJX Companies, Inc., One Kings Lane Inc., Overstock.com, Inc., Ross Stores, Inc., Stein Mart Inc. and Pier 1 Imports, Inc.

 

(ii)                                  Non-Solicitation.  The Executive agrees that during the Restricted Period, other than in connection with the Executive’s duties under this Agreement, the Executive shall not, and shall not use any Confidential Information to, directly or indirectly, either as a principal, manager, agent, employee, consultant, officer, director, stockholder, partner, investor or lender or in any other capacity, and whether personally or through other persons:

 

(a)                                 Solicit business from, interfere with, induce, attempt to solicit business with, interfere with, induce or do business with any actual or prospective customer, client, supplier, manufacturer, vendor or licensor of the Company with whom the Company did business or who the Company solicited within the preceding two (2) years, and who or which: (1) the Executive contacted, called on, serviced or did business with during the Executive’s employment with the Company; (2) the Executive learned of as a result of the Executive’s employment with the Company; or (3) about whom the Executive received Confidential Information.  This restriction applies only to business which is in the scope of services or products provided by the Company or any affiliate thereof; or

 

(b)                                 Solicit, induce or attempt to solicit or induce, engage or hire, on behalf of the Executive or any other person or entity, any person who is an employee or consultant of the Company or who was employed by the Company within the preceding twelve (12) months.

 

(iii)                               Non-Disparagement.  The Executive shall refrain, both during and after the Executive’s employment terminates, from publishing any oral or written statements about the Company or any of the Company’s directors, managers, officers, employees, consultants, agents or representatives that (i) are slanderous, libelous or defamatory; or (ii) place the Company or any of its directors, managers, officers, employees, consultants, agents or representatives in a false light before the public.  The Company shall cause the members of its Board and its officers to

 

10

 

refrain, both during and after the Executive’s employment terminates, from publishing any oral or written statements about the Executive that (i) are slanderous, libelous or defamatory; or (ii) place the Executive in a false light before the public.  A violation or threatened violation of this prohibition may be enjoined by the courts.  The rights afforded the Parties under this provision are in addition to any and all rights and remedies otherwise afforded by law.

 

C.                                    Tolling.  If the Executive violates any of the restrictions contained in this Article IV., the Restricted Period for such restriction(s) violated shall be suspended and all periods of time in which the Executive was in breach of the restrictive covenant(s) shall be added to the Restricted Period for such restrictive covenant(s).

 

D.                                    Remedies.  The Executive acknowledges that the restrictions contained in Article IV. of this Agreement, in view of the nature of the Company’s business and the Executive’s position with the Company, are reasonable and necessary to protect the Company’s legitimate business interests and that a violation of Article IV. of this Agreement may result in irreparable injury to the Company.  In the event of a breach by the Executive of Article IV. of this Agreement, then the Company shall be entitled to seek a temporary restraining order and injunctive relief restraining the Executive from the commission of any breach, and the Parties agree that a bond shall not be required.  If a bond is required to secure such equitable relief, the Parties agree that a bond not to exceed $1,000 shall be sufficient and adequate in all respects to protect the rights and interests of the Parties.  Such remedies shall not be deemed the exclusive remedies for a breach or threatened breach of this Article IV. but shall be in addition to all remedies available at law or in equity, including the recovery of damages from the Executive, the Executive’s agents, any future employer of the Executive, and any person that conspires or aids and abets the Executive in a breach or threatened breach of this Agreement.

 

E.                                     Reasonableness.  The Executive hereby represents to the Company that the Executive has read and understands, and agrees to be bound by, the terms of this Article IV.  The Executive acknowledges that the geographic scope and duration of the covenants contained in this Article IV. are fair and reasonable in light of (i) the nature and wide geographic scope of the operations of the Company’s business; (ii) the Executive’s level of control over and contact with the business in the Restricted Area; and (iii) the amount of compensation, trade secrets and Confidential Information that the Executive is receiving in connection with the Executive’s employment by the Company.  It is the desire and intent of the Parties that the provisions of Article IV. be enforced to the fullest extent permitted under applicable law, whether now or hereafter in effect and therefore, to the extent permitted by applicable law, the Executive and the Company hereby waive any provision of applicable law that would render any provision of Article IV. invalid or unenforceable.

 

F.                                      Reformation.  The Company and the Executive agree that the foregoing restrictions set forth in Article IV. are reasonable under the circumstances and that a breach of the covenants contained in Article IV. may cause irreparable injury to the Company.  The Executive understands that the foregoing restrictions may limit the Executive’s ability to engage in certain businesses anywhere in or involving the Restricted Area during the Restricted Period, but acknowledges that the Executive shall receive Confidential Information and trade secrets, as well as sufficiently high remuneration and other benefits as an employee of the Company to justify such restrictions.  If any of the aforesaid restrictions are found by a court of competent jurisdiction to be unreasonable, or overly broad as to geographic area or time, or otherwise unenforceable, the Parties intend for the restrictions herein set forth to be modified by the court making such determination so as to be reasonable and enforceable and, as so modified, to be fully enforced.  By agreeing to this contractual modification prospectively at this time, the Company and the Executive intend to make this provision enforceable under the law or laws of all applicable jurisdictions so that the entire agreement not to compete and this Agreement as prospectively modified shall remain in full force and effect and shall not be rendered void or illegal.

 

11

 

ARTICLE V.
  MISCELLANEOUS PROVISIONS

 

A.                                    Governing Law.  This Agreement shall be governed by and construed under the laws of the State of Delaware.  Venue of any litigation arising from this Agreement or any disputes relating to the Executive’s employment shall be in the United States District Court for the Northern District of Texas, Dallas Division or a state district court of competent jurisdiction in Dallas County, Texas.  The Executive and the Company consent to personal jurisdiction of the United States District Court for the Northern District of Texas, Dallas Division, or a state district court of competent jurisdiction in Dallas County, Texas for any dispute relating to or arising out of this Agreement or the Executive’s employment, and the Executive and the Company agree that the Executive and the Company shall not challenge personal or subject matter jurisdiction in such courts.

 

B.                                    Legal Fees.  The prevailing party in any action to enforce a term of this Agreement shall be entitled to its reasonable attorneys’ fees and costs incurred to enforce such term.

 

C.                                    Clawback.  The Executive acknowledges and agrees that any compensation paid to the Executive by the Company, pursuant to this Agreement or otherwise, shall be subject to recovery by the Company in accordance with the Company’s clawback policy applicable to executives of the Company, if any, as amended from time to time.

 

D.                                    Code Section 280G.

 

(i)                                     Notwithstanding anything to the contrary in this Agreement, in the event it shall be determined that any payment or distribution made, or benefit provided, by the Company to or for the benefit of the Executive under Article II or Article III (whether paid or payable or distributed or distributable or provided pursuant to the terms hereof or otherwise) or under any other agreement, benefit, plan or policy of the Company (including but not limited to any bonus plan in effect from time to time) (this Agreement and such other agreements, benefits, plans and policies collectively referred to herein as the “Change in Control Arrangements”) would constitute a “parachute payment” as defined in Section 280G of the Internal Revenue Code of 1986, as amended (“Code Section 280G”) (such payments, distributions or other benefits referred to herein as the “Payments”), the Company shall provide the Executive with a computation of (i) the maximum amount of Payments that could be made, without the imposition of the excise tax imposed by Code Section 4999, under the Change in Control Arrangements (said maximum amount being referred to as the “Capped Amounts”); (ii) the value of all Payments that could be made pursuant to the terms of the Change in Control Arrangements (referred to herein as the “Uncapped Payments”); (iii) the dollar amount of excise tax (if any) which the Executive would become obligated to pay pursuant to Code Section 4999 as a result of receipt of the Uncapped Payments (the “Excise Tax Amount”); and (iv) the net value of the Uncapped Payments after reduction by (A) the Excise Tax Amount, (B) the estimated income taxes payable by the Executive on the difference between the Uncapped Payments and the Capped Amount, assuming that the Executive is paying the highest marginal tax rate for state, local and federal income taxes; and (C) the estimated hospital insurance taxes payable by the Executive on the difference between the Uncapped Payments and the Capped Amount based on the hospital insurance tax rate under Code Section 3101 (the “Net Uncapped Amount”).

 

(ii)                                  If the Capped Amount is greater than the Net Uncapped Amount, the Executive shall be entitled to receive or commence to receive Payments equal to the Capped Amount; or if

 

12

 

the Net Uncapped Amount is greater than the Capped Amount the Executive shall be entitled to receive or commence to receive Payments equal to the Uncapped Payments.

 

(iii)                               Any determination required under this Article V.D. shall be made in writing by independent public accountants mutually agreed to by the Company and the Executive (the “Accountants”), whose determination shall be conclusive and binding upon the Executive and the Company for all purposes.  For purposes of making the calculations required by this Article V.D., the Accountants may make reasonable assumptions and approximations concerning applicable taxes and may rely on reasonable, good faith interpretations concerning the application of Code Sections 280G and 4999.  The Company and the Executive shall furnish the Accountants such information and documents as the Accountants may reasonably request in order to make the determinations under this Article V.D.  The Company shall bear all costs the Accountants may reasonably incur in connection with any calculations contemplated by this Article V.D.

 

E.                                     Interpretation; Tax Consequences.  It is intended that this Agreement comply with the provisions of Code Section 409A and the regulations and guidance of general applicability issued thereunder so as to not subject the Executive to the payment of additional interest and taxes under Code Section 409A, and in furtherance of this intent, this Agreement shall be interpreted, operated and administered in a manner consistent with these intentions.  The Executive has reviewed with his own tax advisors the tax consequences of this Agreement and the transactions contemplated hereby.  The Executive is relying solely on his tax advisors and not on any statements or representations of the Company or any of its agents and understands that the Executive (and not the Company) shall be responsible for the Executive’s own tax liability that may arise as a result of this Agreement or the transactions contemplated hereby, except as otherwise specifically provided in this Agreement.

 

F.                                      Waiver of Jury Trial.  EACH OF THE PARTIES IRREVOCABLY WAIVES AND RELEASES TO THE OTHER ITS RIGHT TO A TRIAL BY JURY, AND AGREES THAT IT WILL NOT SEEK A TRIAL BY JURY IN ANY SUCH PROCEEDING.

 

G.                                    Cooperation.  After the termination of the Executive’s employment, the Executive agrees, subject to his other professional and personal commitments to the extent practicable, to provide the Executive’s full cooperation, at the request of the Company, in the transitioning of the Executive’s job duties and responsibilities, and any and all investigations or other legal, equitable or business matters or proceedings which involve any matters for which the Executive worked on or had responsibility during the Executive’s employment with the Company.  The Executive also agrees, subject to his other professional and personal commitments to the extent practicable, to be reasonably available to the Company or its representatives to provide general advice or assistance as requested by the Company.  This includes but is not limited to testifying (and preparing to testify) as a witness in any proceeding or otherwise providing information or reasonable assistance to the Company in connection with any investigation, claim or suit, and cooperating with the Company regarding any investigation, litigation, claims or other disputed items involving the Company that relate to matters within the knowledge or responsibility of the Executive.  Specifically, the Executive agrees, subject to his other professional and personal commitments to the extent practicable, (i) to meet with the Company’s representatives, its counsel or other designees at reasonable times and places with respect to any items within the scope of this provision; (ii) to provide truthful testimony regarding same to any court, agency or other adjudicatory body; (iii) to provide the Company with immediate notice of contact or subpoena by any non-governmental adverse party as to matters relating to the Company, and (iv) to not voluntarily assist any such non-governmental adverse party or such non-governmental adverse party’s representatives.  The Executive acknowledges and understands that the Executive’s obligations of cooperation under this Article V.G. are not limited in time and may include, but shall not be limited to, the need for or availability for testimony; provided, however, that in no event shall the Executive be required to provide

 

13

 

post-termination services to the Company to the extent such post-termination services would be inconsistent with the “separation from service” requirements of Code Section 409A.  The Company shall reimburse the Executive for reasonable expenses incurred in providing cooperation requested by the Company pursuant to this Article V.G.

 

H.                                   Headings.  The paragraph headings contained in this Agreement are for convenience only and shall in no way or manner be construed as a part of this Agreement.

 

I.                                        Severability.  In the event that any court of competent jurisdiction holds any provision in this Agreement to be invalid, illegal or unenforceable in any respect, the remaining provisions shall not be affected or invalidated and shall remain in full force and effect.

 

J.                                        Reformation.  In the event any court of competent jurisdiction holds any restriction in this Agreement to be unreasonable and/or unenforceable as written, the court may reform this Agreement to make it enforceable, and this Agreement shall remain in full force and effect as reformed by the court.

 

K.                                   Entire Agreement.  This Agreement constitutes the entire agreement between the Parties, and fully supersedes any and all prior agreements, understanding or representations between the Parties pertaining to or concerning the subject matter of this Agreement, including, without limitation, the Executive’s employment with the Company.  No oral statements or prior written material not specifically incorporated in this Agreement shall be of any force and effect, and no changes in or additions to this Agreement shall be recognized, unless incorporated in this Agreement by written amendment, such amendment to become effective on the date stipulated in it.  Any amendment to this Agreement must be signed by all Parties to this Agreement.  The Executive acknowledges and represents that in executing this Agreement, the Executive did not rely, and has not relied, on any communications, promises, statements, inducements, or representation(s), oral or written, by the Company, except as expressly contained in this Agreement.  The Parties represent that they relied on their own judgment in entering into this Agreement.  The Executive represents and agrees that he has been given a reasonable time to review this Agreement and has been advised to consult with an attorney, that he fully understands all the provisions of the Agreement, and that he is voluntarily entering into this Agreement.

 

L.                                     Waiver.  No waiver of any breach of this Agreement shall be construed to be a waiver as to succeeding breaches.  The failure of either the Executive or the Company to insist in any one or more instances upon performance of any terms or conditions of this Agreement shall not be construed as a waiver of future performance of any such term, covenant or condition but the obligations of either party with respect thereto shall continue in full force and effect.  The breach by one party to this Agreement shall not preclude equitable relief or the obligations in Article IV.

 

M.                                 Modification.  The provisions of this Agreement may be amended, modified or waived only with the prior written consent of the Company and the Executive, and no course of conduct or failure or delay in enforcing the provisions of this Agreement shall be construed as a waiver of such provisions or affect the validity, binding effect or enforceability of this Agreement or any provision hereof.

 

N.                                    Assignment.  This Agreement shall be binding upon and inure to the benefit of the Parties hereto and their respective heirs, successors and permitted assigns. The Executive may not assign this Agreement to a third party.  The Company may assign its rights, together with its obligations hereunder, to any affiliate and/or subsidiary of the Company or any successor thereto or any purchaser of substantially all of the assets of the Company; provided, however, that the assignee is the successor to all or substantially all of the business and assets of the Company and such assignee expressly assumes all of the obligations, duties and liabilities of the Company set forth in this Agreement.

 

14

 

O.                                    Notices.  Any notice or other communication required, permitted or desired to be given under this Agreement shall be deemed delivered when personally delivered; the next business day, if delivered by overnight courier; the same day, if transmitted by facsimile on a business day before noon, Central Standard Time; the next business day, if otherwise transmitted by facsimile; and the third business day after mailing, if mailed by prepaid certified mail, return receipt requested, as addressed or transmitted as follows (as applicable), or to such other address as a Party may specify by notice given in the same manner:

 

If to the Executive, to the address of the Executive’s principal residence kept in the Company’s records.

 

	
If   to the Company:
    	
Tuesday   Morning Corporation
    
	
 
    	
Attn:   Senior Vice President, General Counsel and Corporate Secretary
    
	
 
    	
6250   LBJ Freeway
    
	
 
    	
Dallas   TX 75240
    
	
 
    	
Fax:   (972) 387-2344
    

 

P.                                      Counterparts.  This Agreement may be executed in two or more identical counterparts, all of which shall be considered a single instrument.

 

[REMAINDER OF PAGE INTENTIONALLY LEFT BLANK.  SIGNATURE PAGE FOLLOWS.]

 

15

 

IN WITNESS WHEREOF, the Company and the Executive have caused this Agreement to be executed and effective on the date first set forth above.

 

 

	
THE   COMPANY:
    	
TUESDAY   MORNING CORPORATION
    
	
 
    	
 
    
	
 
    	
 
    
	
 
    	
By:
    	
/s/   Stephanie Bowman
    
	
 
    	
Printed   Name:
    	
Stephanie   Bowman
    
	
 
    	
Title:
    	
EVP,   Chief Financial Officer
    
	
 
    	
 
    
	
 
    	
 
    
	
THE   EXECUTIVE:
    	
/s/   R. Michael Rouleau
    
	
 
    	
R.   Michael Rouleau
    
				

 

16

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00220-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00220-of-00352.parquet"}]]